...
Dataset wrap |
---|
|
Rowcaps |
---|
Rows 1-20: | Show several analytes (as noted in the PTTEST) in the E-Liquid substance for the condition noted in PTTSTCND which is Condition 1. | Rows 2, 12, 13: | Show the Nicotine, 4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), and N-nitrosonornicotine analytes in the Aerosol substance represented using the PTSPEC variable. | Rows 17, 18: | Show microbials, TAMC and TYMC (PTTEST and PTTESTCD), used in testing (aerobic plate count, mold, and yeast) using the PTSCAT variable. The E-Liquid substance has the condition represented using the PTTSTCND which is Condition 1. |
|
Dataset2 |
---|
Row | STUDYID | DOMAIN | SPTOBID | SPDEVID | STOCONDID | PTSEQ | PTREFID | PTTESTCD | PTTEST | PTCAT | PTSCAT | PTORRES | PTORRESU | PTLLOD | PTSTRESC | PTSTRESN | PTSTRESU | PTSPEC | PTSPCCND | PTMETHOD | PTLLOQ | PTREPNUM | PTTPT | PTTPTNUM |
---|
1 | TOB07 | PT | 111 |
| Condition 1 | | VAP77777.1 | NICOTINE | Nicotine | STABILITY STUDY |
| 35.94 | mg/g |
| 35.94 | 35.94 | mg/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 2 | TOB07 | PT | 111 |
| Condition 1 | 2 | VAP77777.1 | NICOTINE | Nicotine | STABILITY STUDY |
| | mg/PUFF |
| 0.1039 | 0.1039 | mg/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 3 | TOB07 | PT | 111 |
| Condition 1 | 3 | VAP77777.1 | NORNCTN | | STABILITY STUDY | Nicotine Degradant | 25.76 | ug/g |
| 25.76 | 25.76 | ug/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 4 | TOB07 | PT | 111 |
| Condition 1 | 34 | VAP77777.1 | NORNCTN | | STABILITY STUDY | Nicotine Degradant | 0.0392 | ug/PUFF |
| 0.0392 | 0.0392 | ug/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 5 | TOB07 | PT | 111 |
| Condition 1 | 5 | VAP77777.1 | GLYCRL | Glycerol | STABILITY STUDY | Primary Ingredient | 615.68 | mg/g |
| 615.68 | 615.68 | mg/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 6 | TOB07 | PT | 111 |
| Condition 1 | 56 | VAP77777.1 | GLYCRL | Glycerol | STABILITY STUDY | Primary Ingredient | 1.81 | mg/PUFF | 0.00144 | 1.81 | 1.81 | mg/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 7 | TOB07 | PT | 111 |
| Condition 1 | 67 | VAP77777.1 | PRPYLGLY | Propylene Glycol | STABILITY STUDY | Primary Ingredient | 218.21 | mg/g |
| 218.21 | 218.21 | mg/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 8 | TOB07 | PT | 111 |
| Condition 1 | 68 | VAP77777.1 | PRPYLGLY | Propylene Glycol | STABILITY STUDY | Primary Ingredient | 0.8565 | mg/PUFF | 0.00024 | 0.8565 | 0.8565 | mg/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 9 | TOB07 | PT | 111 |
| Condition 1 | 79 | VAP77777.1 | BNZOICAC | Benzoic Acid | STABILITY STUDY | Acid | 42.2 | ug/PUFF |
| 42.2 | 42.2 | ug/PUFF | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 10 | TOB07 | PT | 111 |
| Condition 1 | 810 | VAP77777.1 | MENTHOL | Menthol | STABILITY STUDY | Flavorant | 37.53 | mg/g |
| 37.53 | 37.53 | mg/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 11 | TOB07 | PT | 111 |
| Condition 1 | 811 | VAP77777.1 | MENTHOL | Menthol | STABILITY STUDY | Flavorant | 0.5881 | mg/PUFF | 0.00024 | 0.5881 | 0.5881 | mg/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 12 | TOB07 | PT | 111 |
| Condition 1 | 12 | VAP77777.1 | GLYCDOL | Glycidol | STABILITY STUDY | Stabilizer | <Limit of Detection (LOD) |
| 0.00011 | <Limit of detection (LOD) |
|
| AEROSOL |
|
|
| 1 | Week 0 | 1 | 13 | TOB07 | PT | 111 |
| Condition 1 | 13 | VAP77777.1 | FRMLDHD | Formaldehyde | STABILITY STUDY |
| 0.0728 | ug/PUFF | 0.00549 | 0.0728 | 0.0728 | ug/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 14 | TOB07 | PT | 111 |
| Condition 1 | 14 | VAP77777.1 | ACROLN | Acrolien | STABILITY STUDY |
| <Limit of Quantification (LOQ) |
| 0.00928 | Limit of Quantification (LOQ) |
|
| AEROSOL |
|
|
| 1 | Week 0 | 1 | 15 | TOB07 | PT | 111 |
| Condition 1 | 15 | VAP77777.1 | LACTICAC | Lactic Acid | STABILITY STUDY |
| 40.44 | ug/g |
| 40.44 | 40.44 | ug/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 16 | TOB07 | PT | 111 |
| Condition 1 | 16 | VAP77777.1 | LACTICAC | Lactic Acid | STABILITY STUDY |
| 29.71 | ug/PUFF | 0.284 | 29.71 | 29.71 | ug/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 17 | TOB07 | PT | 111 |
| Condition 1 | 917 | VAP77777.1 | VANLLN | Vanillin | STABILITY STUDY | Flavorant | 1.12 | ug/g |
| 1.12 | 1.12 | ug/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 18 | TOB07 | PT | 111 |
| Condition 1 | 1018 | VAP77777.1 | NNK | Nicotine-Derived Nitrosamine Ketone | STABILITY STUDY | HPHC | 0.0711 | ug/g |
| 0.0711 | 0.0711 | ug/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 19 | TOB07 | PT | 111 |
| Condition 1 | 1119 | VAP77777.1 | NNN | N-Nitrosonornicotine | STABILITY STUDY | HPHC | 0.0852 | ug/g |
| 0.0852 | 0.0852 | ug/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 20 | TOB07 | PT | 111 |
| Condition 1 | 1220 | VAP77777.1 | NNK | Nicotine-Derived Nitrosamine Ketone | STABILITY STUDY | HPHC | 0.0577 | ug/PUFF |
| 0.0577 | 0.0577 | ug/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 21 | TOB07 | PT | 111 |
| Condition 1 | 1321 | VAP77777.1 | NNN | N-Nitrosonornicotine | STABILITY STUDY | HPHC | 0.0742 | ug/PUFF |
| 0.0742 | 0.0742 | ug/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 22 | TOB07 | PT | 111 |
| Condition 1 | 1422 | VAP77777.1 | NICKEL | Nickel | STABILITY STUDY | Extractables / Leachables | 0.0897 | ug/g |
| 0.0897 | 0.0897 | ug/g | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 23 | TOB07 | PT | 111 |
| Condition 1 | 1423 | VAP77777.1 | MASS | Mass | STABILITY STUDY |
| 3.87 | mg/PUFF | 0.0071 | 3.87 | 3.87 | mg/PUFF | AEROSOL |
|
|
| 1 | Week 0 | 1 | 24 | TOB07 | PT | 111 |
| Condition 1 | 1424 | VAP77777.1 | CHROMIUM | Chromium | STABILITY STUDY |
| NOT DETECTED |
|
| NOT DETECTED |
|
| E-LIQUID |
|
|
| 1 | Week 0 | 1 | 25 | TOB07 | PT | 111 |
| Condition 1 | 1525 | VAP77777.1 | PH | pH | STABILITY STUDY |
| 7.15 |
|
| 7.15 | 7.15 |
| E-LIQUID |
|
|
| 1 | Week 0 | 1 | 26 | TOB07 | PT | 111 |
| Condition 1 | 1526 | VAP77777.1 | PH | pH | STABILITY STUDY |
| 7.24 |
|
| 7.24 | 7.24 |
| AEROSOL |
|
|
| 1 | Week 0 | 1 | 27 | TOB07 | PT | 111 |
| Condition 1 | 1627 | VAP77777.1 | ENDTXN | Endotoxin | STABILITY STUDY | Toxins | NOT DETECTED |
|
| NOT DETECTED |
|
| E-LIQUID |
|
|
| 1 | Week 0 | 1 | 28 | TOB07 | PT | 111 |
| Condition 1 | 1728 | VAP77777.1 | AEBPLCT | Aerobic Plate Count | STABILITY STUDY | Microbiological | <1 | CFU/mL |
| <1 | <1 | CFU/mL | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 29 | TOB07 | PT | 111 |
| Condition 1 | 1829 | VAP77777.1 | TYMC | Total Yeast and/or Mold Count | STABILITY STUDY | Microbiological | 1 | CFU/mL |
| 1 | 1 | CFU/mL | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 30 | TOB07 | PT | 111 |
| Condition 1 | 1930 | VAP77777.1 | ACTALD | Acetaldehyde | STABILITY STUDY | Aldehyde | 7.8 | ug/mL |
| 7.8 | 7.8 | ug/mL | E-LIQUID |
|
|
| 1 | Week 0 | 1 | 31 | TOB07 | PT | 111 |
| Condition 1 | 2031 | VAP77777.1 | ACTPROPN | Acetyl Propionyl | STABILITY STUDY | Diketone | 32.4 | ug/mL |
| 32.4 | 32.4 | ug/mL | E-LIQUID |
|
|
| 1 | Week 0 | 1 |
|
|
A Shelf Life study dataset would shows analytes done in different test conditions with replicates over time points. In the interest of brevity for this example, only portions of the content using the TEST of Nicotine is shown in a sample of timepoints in two conditions with replicates. The weeks reflective of Week 1, Week 2, Week 3, etc. which would align with the PTTPTNUM of 2,3, etc. are not shown for visual viewing purposes. This is an example, this provides possible tests that might be used to demonstrate how to use the datasets and variables to show what was done for the shelf-life stability study. It shows what timepoint and what type of data follows. It is important to show different test conditions for each analyte. For aerosol a machine similutaion is use so mg/puff is valid.
...